[Sustained hematologic complete response after discontinuation of ropeginterferon alfa-2b in patients with polycythemia vera].
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
We report two cases of polycythemia vera (PV) treated with ropeginterferon alfa-2b (ropeg-IFN) in which hematologic control was maintained without therapy after treatment discontinuation. The patients achieved complete response (CR) at 14 and 22 weeks after treatment initiation, respectively. After discontinuation of ropeg-IFN, Patient 1 has maintained hematocrit (Ht)
Fields of Study & Subjects
Myeloproliferative Neoplasms: Diagnosis and Treatment
Platelet Disorders and Treatments
Hematological disorders and diagnostics
Publication details
- Journal / source
- PubMed
- Volume
- 67
- Issue
- 3
- Pages
- 205–208
- Publication date
- 1 January 2026
- Language
- JA